Company Name

Industry

Location

Revenue

Employees

Orbital Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Mariana Oncology

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

BiologicsCorp

Biotechnology

United States, Indiana

$250M to $500M

11-50

Hongene Biotech Corporation

Biotechnology

United States, California

$250M to $500M

11-50

Targeted Bioscience

Biotechnology

United States, Florida

$250M to $500M

11-50

CAMP4 Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Rectify Pharma

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Cellorama

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

iECURE

Biotechnology

United States, Pennsylvania

$250M to $500M

11-50

Fulcrum Genomics

Biotechnology

United States, Colorado

$250M to $500M

11-50

Halda Therapeutics

Biotechnology

United States, Connecticut

$250M to $500M

11-50

Theragent

Biotechnology

United States, California

$250M to $500M

11-50

LEAP Technologies

Biotechnology

United States, North Carolina

$250M to $500M

11-50

Coleparmer

Biotechnology

United States, Illinois

$250M to $500M

11-50

Allen Institute for Immunology

Biotechnology

United States, Washington

$250M to $500M

11-50

Uvax Bio

Biotechnology

United States, Delaware

$250M to $500M

11-50

InduPro

Biotechnology

United States, Washington

$250M to $500M

11-50

Orange County Bio

Biotechnology

United States, California

$250M to $500M

11-50

Switch Therapeutics

Biotechnology

United States, California

$250M to $500M

11-50

Reskin Medical

Biotechnology

United States, Utah

$250M to $500M

11-50